A detailed history of Beck Mack & Oliver LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 21,503 shares of ABBV stock, worth $3.84 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
21,503
Previous 22,333 3.72%
Holding current value
$3.84 Million
Previous $3.83 Million 10.86%
% of portfolio
0.1%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $135,987 - $165,443
-830 Reduced 3.72%
21,503 $4.25 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $921,774 - $1.08 Million
-5,955 Reduced 21.05%
22,333 $3.83 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $194,341 - $221,433
-1,216 Reduced 4.12%
28,288 $5.15 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $18,300 - $20,611
-133 Reduced 0.45%
29,504 $4.57 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $534,493 - $618,754
-4,001 Reduced 11.89%
29,637 $4.42 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $255,081 - $317,432
-1,925 Reduced 5.41%
33,638 $4.53 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $59,290 - $68,281
-410 Reduced 1.14%
35,563 $5.67 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $17,288 - $20,733
-125 Reduced 0.35%
35,973 $5.82 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $11,810 - $13,545
-88 Reduced 0.24%
36,098 $4.85 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $192,943 - $245,293
-1,402 Reduced 3.73%
36,186 $5.54 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $56,751 - $70,412
-430 Reduced 1.13%
37,588 $6.09 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $22,775 - $28,817
-212 Reduced 0.55%
38,018 $5.15 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $84,694 - $96,140
796 Added 2.13%
38,230 $4.12 Million
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $151,291 - $168,547
-1,438 Reduced 3.7%
37,434 $4.22 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $95,957 - $105,637
-938 Reduced 2.36%
38,872 $4.21 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $6,036 - $8,150
-75 Reduced 0.19%
39,810 $4.27 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $34,364 - $40,332
-400 Reduced 0.99%
39,885 $3.49 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $131,919 - $176,527
1,798 Added 4.67%
40,285 $3.96 Million
Q1 2020

May 05, 2020

SELL
$64.5 - $97.79 $133,837 - $202,914
-2,075 Reduced 5.12%
38,487 $2.93 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $541,628 - $651,192
-8,600 Reduced 17.49%
40,562 $3.07 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $754,236 - $964,090
-11,480 Reduced 18.93%
49,162 $3.58 Million
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $112,238 - $132,099
-1,455 Reduced 2.34%
60,642 $4.89 Million
Q4 2018

Feb 04, 2019

SELL
$77.85 - $96.01 $105,875 - $130,573
-1,360 Reduced 2.14%
62,097 $5.73 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $84,464 - $93,898
-950 Reduced 1.47%
63,457 $6 Million
Q2 2018

Jul 25, 2018

SELL
$89.78 - $106.23 $46,236 - $54,708
-515 Reduced 0.79%
64,407 $0
Q1 2018

Apr 25, 2018

SELL
$92.01 - $123.21 $144,455 - $193,439
-1,570 Reduced 2.36%
64,922 $0
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $76,126 - $83,478
-850 Reduced 1.26%
66,492 $0
Q3 2017

Oct 27, 2017

BUY
$69.85 - $89.22 $4.7 Million - $6.01 Million
67,342
67,342 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.